SCHEMBL6893551

SCHEMBL6893551

CCCCOC(=O)N(CCO)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.47
TDP1 Q9NUW8 3/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
JAK2 O60674 1/20 0.47
PAX8 Q06710 1/20 0.47
TP53 P04637 2/20 0.46
CYP3A4 P08684 3/20 0.44
CHRM2 P08172 3/20 0.44
CHRM1 P11229 3/20 0.44
CHRM3 P20309 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
GAA P10253 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 7/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11430998 0.91 TSHR (0.50) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL4919040 0.87 TSHR (0.46) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL4920502 0.86 NPC1 (0.48) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL11546490 0.85 TSHR (0.50) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL6240933 0.84 SMN1; SMN2 (0.56) TSHRL3MBTL1NPC1RAB9AJAK2
SCHEMBL27983244 0.84 NPC1 (0.59) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL6717574 0.84 TSHR (0.49) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL4921591 0.84 TSHR (0.49) TSHRTDP1L3MBTL1NPC1RAB9A
SCHEMBL11432478 0.81 TP53 (0.51) TSHRNPC1RAB9AJAK2PAX8
SCHEMBL9308576 0.81 TSHR (0.46) TSHRTDP1L3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0405537-B1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives WARNER LAMBERT CO (US) 2004-09-08 EP disclosed
US-5631281-A COMPOUNDS FOR TREATMENT OF ANXIETY WITH INDOLE AMIDES WARNER-LAMBERT COMPANY (US) 1997-05-20 US disclosed
US-5622983-A ANTIOBESITY AGENTS, ANTIPSYCHOTIC AGENTS, ANTIULCER AGENTS WARNER-LAMBERT COMPANY (US) 1997-04-22 US disclosed
US-5580896-A Treatment of pain and colorectal cancer with dipeptoids of α-substituted Trp-Phe derivatives WARNER-LAMBERT COMPANY (US) 1996-12-03 US disclosed
EP-0479910-A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED Trp-Phe- AND PHENETHYLAMINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1992-04-15 EP disclosed
WO-1991000274-A1 N-SUBSTITUTED CYCLOALKYL AND POLYCYCLOALKYL ALPHA-SUBSTITUTED TRP-PHE- AND PHENETHYLAMINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1991-01-10 WO disclosed
EP-0405537-A1 N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives WARNER-LAMBERT COMPANY (US) 1991-01-02 EP disclosed